Statins and diabetes mellitus: price of collaboration
It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patientswith diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials shows statins to increaseglycemic levels and incid...
Saved in:
Main Authors: | Andrey Alexeevich Aleksandrov, Maria Nikolaevna Yadrikhinskaya, Svetlana Semenovna Kukharenko, Olga Alexandrovna Shatskaya |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/d1621016038b4a5abe471d23edeb8a2c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2010) -
Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011) -
Statin use and risk of diabetes mellitus
by: Oksana Mikhailovna Drapkina, et al.
Published: (2012) -
ACE inhibitors as a risk factor for hypoglycemia
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2011) -
Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
by: Victoriya N. Serebryakova, et al.
Published: (2021)